76Br-16alpha,17alpha-dioxolane progestin analogs (Washington University/University of Illinois)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name76Br-16alpha,17alpha-dioxolane progestin analogs (Washington University/University of Illinois)
Drug Alias NameN/A
ClassificationRadiation-emitting products
Mechanisms of ActionProgesterone modulators
TargetsProgesterone
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWashington University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWashington UniversityUniversity Of Illinois
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A